Altimmune announces submission of investigational new drug application for adcovid™ a single-dose intranasal covid-19 vaccine; on track to commence phase 1 clinical study in december

Simple, single-dose nasal spray offers greater ease and comfort of administration ; positioning adcovid as a differentiated vaccine candidate for adults and children

ALT Ratings Summary

ALT Quant Ranking